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A T Cell–Specific Enhancer in the Interleukin-3
Locus Is Activated Cooperatively by Oct and NFAT
Elements within a DNase I–Hypersensitive Site
Kym N. Duncliffe, Andrew G. Bert, Mathew A. Vadas, CsA is known to function by inhibiting the Ca21-depen-
dent phosphatase calcineurin, and one of the principleand Peter N. Cockerill
targets of CsA is the NFATp/c family of transcriptionDivision of Human Immunology
factors (Clipstone and Crabtree, 1992; Jain et al., 1993;Hanson Centre For Cancer Research
O’Keefe et al., 1992; Rao, 1994; Schreiber and Crabtree,Institute for Medical and Veterinary Science
1992).Frome Road
The human GM-CSF gene lies just 10 kb downstreamAdelaide 5000
of the IL-3 gene (Yang et al., 1988) and is activated byAustralia
an inducible CsA-sensitive enhancer located between
the two genes (Cockerill et al., 1993, 1995b). Although
the GM-CSF enhancer has the potential to activateSummary
both the IL-3 and the GM-CSFpromoters (Cockerillet al.,
1993; Osborne et al., 1995), it is likely that this enhancerInterleukin-3 (IL-3) is a cytokine that is expressed pri-
functions predominantly to regulate GM-CSF gene ex-marily in activated T cells. Here we identified an induc-
pression. The GM-CSF enhancer resides just upstreamible T cell–specific enhancer 14 kb upstream of the IL-3
of the GM-CSF gene and is active not only in T cellsgene that responded to activation of T cell receptor
but also in cell types such as endothelial cells, whichsignaling pathways. The IL-3 enhancer spanned an
express GM-CSF but not IL-3 (Cockerill et al., 1995a).inducible cyclosporin A–sensitive DNase I–hypersen-
Although several inducible transcription factor–bind-sitive site found only in T cells. Four NFAT-like ele-
ing sites exist in the human IL-3 promoter, the basisments exist within the enhancer. The two most active
for the cell specificity of IL-3 gene expression remainsNFAT-like elements were located at the center of the
unclear. In common with many other cytokine genes,DNase I–hypersensitive site. One of these NFAT-like
the human IL-3 promoter encompasses binding siteselements encompassed overlapping Oct- and NFATp/
for transcription factors such as AP-1, Elf-1, Oct-1, andc-binding sites, which functioned in a highly syner-
CBF, and a CK-1 element (Cameron et al., 1994; Daviesgistic manner. We suggest that the T cell–specific ex-
et al., 1993; Gottschalk et al., 1993; Mathey-Prevot etpression of the IL-3 gene is partly controlled through
al., 1990; Park et al., 1993; Shannon et al., 1988; Shoe-the enhancer by cooperation between Oct and NFAT
maker et al., 1990). None of these factors alone is re-family proteins.
sponsible for T cell–specific gene expression, as all of
these factors can function in cells other than T cells. It
Introduction has been suggested, however, that closely linked AP-1
and Elf-1 binding sites in the IL-3 promoter can direct
Immune and inflammatory responses are orchestrated T cell–specific expression (Gottschalk et al., 1993). Other
by a large network of inducible cytokines (Nicola, 1989). factors that may activate the IL-3 promoter include fac-
Specific responses rely on both the site and nature of tors that bind the NF-IL3A element (Davies et al., 1993;
cytokine gene expression. To approach the subject of Zhang et al., 1995) and zinc finger proteins that bind the
cytokine gene regulation, we chose to study the closely GC-rich region (Koyano-Nakagawa et al., 1994).
linked interleukin-3 (IL-3) and granulocyte/macrophage The NFATp/c family of transcription factors represent
colony-stimulating factor (GM-CSF) genes (Gasson, candidates for factors that might also be implicated in
1991; Masuda et al., 1993; Yang et al., 1988). This pres- IL-3 gene regulation (Rao, 1994). The IL-3 gene has a
ents a valuable model for studying inducible cytokine pattern of Ca21 inducibility and CsA sensitivity in com-
gene expression as these related genes are induced via mon with other cytokines expressed in T cells, such as
similar signaling pathways, yet in some cell types they IL-2, IL-4, IL-5, and GM-CSF, that each utilize NFATp/c
are differentially regulated. As our previous studies sites for their activation (Cockerill et al., 1995b; Masuda
(Cockerill et al., 1993) have not revealed thebasis for this et al., 1993; Rao, 1994; Tsuruta et al., 1995). In the case of
differential regulation, we chose here to seek additional the IL-2 promoter and the GM-CSF enhancer, NFATp/c
mechanisms for IL-3 gene regulation. binds to DNA in close association with the AP-1 family
IL-3 is a cytokine that regulates the growth and differ- of transcription factors (Curran and Franza, 1988) to
entiation of hematopoietic progenitor cells (Nicola, form a higher order complex termed NFAT (Boise et al.,
1989). IL-3 acts on both early stem cells and progenitors 1993; Cockerill et al., 1993, 1995b; Jain et al., 1992;
committed to distinct lineages that include monocytes, Nolan, 1994; Northrop et al., 1993). At these sites, and
granulocytes, megakaryocytes, erythrocytes, eosino- at sites in the IL-4 promoter, NFATp/c associates with
phils, and mast cells. The human IL-3 gene is tightly the consensus sequence T/AGGAA/GAA/GA/T (Cock-
regulated and is expressed primarily in activated T cells erill et al., 1995b; Masuda et al., 1993; Rao, 1994). In
and natural killer cells. The IL-3 gene is induced in T the GM-CSF enhancer and the IL-2 promoter, T/AGG
cells predominantly in response to T cell receptor (TCR) AA/GAA/GA/TNTGAGTCA defines an arrangement of
activation (Masuda et al., 1993). Like IL-2, IL-4, IL-5, and NFATp/c- and AP-1-like motifs able to support coopera-
GM-CSF, IL-3 gene expression in activated T cells is tive binding of NFATp/c and AP-1 (Cockerill et al.,
repressed in the presence of the immunosuppressant 1995b). NFATp/c was initially described as a lymphoid-
specific factor (Shaw et al., 1988), but is now known tocyclosporin A (CsA) (Masuda et al., 1993; Rao, 1994).
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comprise a large family of proteins, the best character-
ized of which are NFATp and NFATc (Hoey et al., 1995;
Masuda et al., 1995; McCaffrey et al., 1993; Northrop et
al., 1994). Although NFATc is largely lymphoid specific,
NFATp is more widely expressed (Northrop et al., 1994).
The utilization of NFATp and AP-1 by the GM-CSF en-
hancer may partly account for the activity of the GM-
CSF locus not only in T cells but also in other cell types
that express these factors (Cockerill et al., 1995a).
To identify DNA elements that regulate IL-3 expres-
sion, we have previously mapped DNase I–hypersensi-
tive (DH) sites across the IL-3/GM-CSF locus (Cockerill
et al., 1993; see Figure 7). We located a cluster of four
DH sites spanning a 4 kb region immediately upstream
of the IL-3 gene and another cluster of three DH sites
just downstream from the IL-3 gene. However, these DH
sites are constitutively present in T cells and do not
appear to respond to TCR activation.
To identify additional DNA elements that control the
regulation of IL-3 gene expression, we sought DH sites
further upstream of the IL-3 gene. Here we report the
identification of aninducible T cell–specific DH site 14 kb
upstream of the IL-3 gene that functions as an inducible
Figure 1. A T Cell–Specific DH Site Exists Upstream of the IL-3 Gene
enhancer. This enhancer may cooperate with other up-
DH sites were mapped in DNase I–digested nuclei isolated from
stream and downstream elements in the control of the Jurkat cells, HEL fibroblasts, HeLa cells, and Ball-1 B cells. Where
T cell–specific expression of the IL-3 gene. indicated, cells were either untreated (nil) or treated for 4 hr with
combinations of PMA/I, 0.1 mM CsA, and 20 mg/ml cycloheximide
(CHX) as previously described (Cockerill et al., 1993). The upper
panel is a Southern blot of BamHI-digested DNA samples probedResults
upstream from a BamHI site located 10 kb 59 of the IL-3 gene. The
lower panel is a Southern blot of the same DNA samples digestedA T Cell–Specific DH Site Resides Upstream
with EcoRI and probed under conditions used previously to map a
of the IL-3 Gene DH site upstream of the GM-CSF gene (Cockerill et al., 1993). The
In a previous study we mapped DH sites located within arrows indicate the locations of inducible DH sites 14 kb upstream
12 kb of the human IL-3 gene (Cockerill et al., 1993). of the IL-3 gene and within the GM-CSF enhancer. The IL-3 DH site
was located 3.8 kb upstream of the BamHI site that delimits theHere we sought additional regulatory elements by map-
probe.ping DH sites within a 25 kb region extending upstream
from a BamHI site that exists 10 kb upstream of the IL-3
gene (Frolova et al., 1991). As a control we used the
site existed as a broad region approximately 200 bpsame DNase I–digested DNA samples to probe for the
across that was centered midway between SphI andinducible DH site that we previously identified within
XbaI sites located 300 bp apart (data not shown; Frolovathe GM-CSF enhancer (Cockerill et al., 1993).
et al., 1991).In Jurkat T cells we identified a DH site 14 kb upstream
At least two additional DH sites were detected in theof the IL-3 gene that in many ways resembled the DH
IL-3 locus further upstream of the DH site located atsite located within the GM-CSF enhancer (arrows in Fig-
214 kb, but the bands representing these sites existedure 1). Both DH sites were induced by the combination
in a poorly resolved upper region of the Southern blotof phorbol ester and calcium ionophore A23187 (PMA/I),
(Figure 1). These DH sites resided approximately 20andsignals that mimic TCR activation pathways. As pre-
25 kb upstream of the IL-3 gene and were more visibleviously shown for the GM-CSF enhancer DH site (Cock-
with increased DNase I digestion (Figure 1, lane 3).erill et al., 1993), the IL-3 DH site first appeared about
1–2 hr after stimulation, just before the onset of IL-3 and
GM-CSF transcription (data not shown). The induction The Upstream DH Site Is an Inducible T
Cell–Specific Enhancerof each DH site was inhibited in the presence of either
the immunosuppressant CsA or the protein synthesis A 1.2 kb BglII fragment of DNA encompassing the induc-
ible DH site at 214 kb was tested for enhancer functioninhibitor cycloheximide (Figure 1). Significantly, how-
ever, the IL-3 DH site exhibited the properties of a T in Jurkat T cells. This fragment extended from 0.6 kb
upstream to 0.3 kb downstream of the 300 bp SphI–XbaIcell–specific DH site. While Jurkat cells had both DH
sites, the GM-CSF enhancer DH site, but not the IL-3 segment that spans the DH site. Enhancer function was
assessed by inserting the 1.2 kb BglII fragment in frontofDH site, was induced by PMA/I in cell lines that express
GM-CSF but not IL-3 (human embryonic lung [HEL] fi- the IL-3 promoter in a luciferase reporter gene plasmid.
Plasmids were transiently transfected into Jurkat cells,broblasts and HeLa cells). No inducible DH sites were
detected in the Ball-1 B cell line, which expressesneither cultured for 20 hr, and then stimulated for 9 hr in the
presence of PMA/I before cell extracts were harvestedIL-3 or GM-CSF. By including restriction enzyme–
digested control samples, we determined that the DH for luciferase activity.
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the same as the 1.2 kb BglII fragment (pIL3H-NA330;
Figures 2A and 3A). Further deletions at the edges of
the enhancer generated a 220 bp HinfI–XbaI fragment
(see Figure 3A), which was only marginally less active
than the 330 bp and 1.2 kb enhancer fragments (pIL3H-
HX220; Figure 2A).
The kinetics of IL-3 enhancer and promoter activation
(Figure 2B) mirrored the previously described kinetics
of IL-3 mRNA induction in Jurkat cells stimulated with
PMA/I (Cockerill et al., 1993). In the presence of the
enhancer, IL-3 promoter activity was increased by 4- to
5-fold at each timepoint between 7 and 15 hr, with peak
activation occurring after 9 hr of stimulation (Figure 2B).
The IL-3 enhancer also activated heterologous pro-
moters in stimulatedJurkat cells. Whenplaced in front of
the thymidine kinase promoter, the 1.2 kb IL-3 enhancer
fragment increased luciferase reporter gene expression
by 4-fold (Figure 2C). When placed in front of the GM-
CSF promoter, the IL-3 enhancer increased luciferase
gene activity by 2- to 3-fold (Figure 2D).
As the GM-CSF gene is active in numerous cell types,
the GM-CSF promoter/luciferase plasmid was used as
a vehicle to test the cell specificity of the IL-3 enhancer,
with a simian virus 40 (SV40) enhancer/GM-CSF pro-
moter plasmid also included as a control. The SV40
enhancer is highly active in a range of cell types, and
the 158 bp SV40 enhancer fragment used here is also
known to support the formation of a DH site (Jongstra
et al., 1984). Each enhancer/promoter plasmid was
transfected into Jurkat T cells, CEM T cells, endothelial
cells (HUVEC), KG1a myeloid leukemic cells, and 5637
bladder carcinoma cells and activated with PMA/I. Each
of these cell types can express GM-CSF, but only Jurkat
and CEM cells express IL-3. In stimulated Jurkat cells
Figure 2. An Inducible Enhancer Spans the Inducible DH Site Up-
the activity of the IL-3 enhancer was similar to that ofstream of the IL-3 Gene
the SV40 enhancer (Figure 2D). In stimulated CEM T
DNA fragments encompassing the upstream IL-3 DH site were
cells, the IL-3 enhancer elevated promoter activity bytested for enhancer function in cells transiently transfected with
5- to 10-fold,but was not as activeas the SV40 enhancer.luciferase reporter gene plasmids.
(A) IL-3 enhancer function upstream of the IL-3 promoter in Jurkat In marked contrast with the SV40 enhancer, the IL-3
cells stimulated with PMA/I for 9 hr in the presence or absence of enhancer was inactive in stimulated HUVEC, KG1a, and
0.1 mM CsA. 5637 cells (Figure 2D).
(B) Time course of IL-3 promoter (pIL3) and IL-3 promoter/enhancer
(pIL3B1.2) induction in Jurkat cells stimulated with PMA/I.
(C) IL-3 enhancer function upstream of the thymidine kinase pro-
The IL-3 Enhancer Encompasses Fourmoter in Jurkat cells stimulated with PMA/I for 9 hr.
NFATp/c Sites(D) Activities of the IL-3 and SV40 enhancers upstream of the GM-
CSF promoter/luciferase gene plasmid pGM in the indicated cell To aid identification of DNA elements that mediate the
types stimulated for 9 hr with PMA/I. inducible CsA-sensitive activity of the IL-3 enhancer, we
(A), (C), and (D) all include standard error of the mean and represent determined the DNA sequence in the region of the DH
4 to 11 independent transfections for each plasmid. Note that the site (Figure 3A) and scanned it for NFATp/c consensus
plasmid pIL3 has inducible CsA-sensitive properties different from
binding sites (Cockerill et al., 1995b) and other transcrip-those of the CsA-resistant IL-3 promoter/CAT reporter plasmid
tion factor–binding sites recorded in the Signal ScanpHIL3 (Cockerill et al., 1993) used in our earlier studies.
data base (Prestridge, 1991). The enhancerwas found to
contain four sites that were either identical to or closelyThe inducible activity of the IL-3 promoter was in-
resembled the NFATp/c consensus sequence T/AGcreased by 2- to 3-fold in the presence of the enhancer
GAA/GAA/GA/T (Figure 3). These sites, in accordanceregardless of whether the enhancer was inserted in its
with their approximate locations in the sequence, werenatural or reverse orientation relative to the promoter
termed the IL70, IL140, IL190, and IL280 elements. The(Figure 2A). The inducible activity of each of the IL-3
IL140 and IL190 elements bore the closest match to thepromoter/enhancer constructs was essentially elimi-
NFATp/c consensus and were located at the center ofnated in the presence of 0.1 mM CsA. Functional assays
the DH site. Interestingly, the IL190 and IL280 elementsof segments of the 1.2 kb enhancer indicated that en-
both appeared to be composite sites. The IL190hancer activity was concentrated within the region of
NFATp/c site overlapped an octamer element (Staudtthe DH site. A 330 bp NsiI–AccI fragment that encom-
passed the DH site had an enhancer activity essentially and Lenardo, 1991), and the IL280 NFATp/c site was
Immunity
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Figure 3. Sequences of the IL-3 Enhancer and NFAT-like Elements
(A) DNA sequence of the SphI–XbaI fragment of DNA encompassing the IL-3 enhancer core and DH site. Consensus transcription factor–binding
sites (boxed) were identified with the aid of a computer data base (Prestridge, 1991) and the NFATp/c consensus derived from the GM-CSF
enhancer and IL-2 promoter NFAT motifs (Cockerill et al., 1995b). Brackets encompass DNA sequences used to construct the oligonucleotides
used in subsequent binding assays and construction of luciferase reporter plasmids.
(B) Sequences of NFAT-like elements that exist in the IL-3 enhancer (IL70, IL140, IL190, and IL280), the GM-CSF enhancer (GM330, GM420,
and GM550), and the IL-2 promoter (hIL2). Highlighted are conserved GGA sequences that act as NFATp/c sites and TCA sequences that
form part of AP-1-binding sites. Altered bases in the IL190 mutants are shown in lowercase. Below is the NFAT consensus sequence derived
from the IL-2 and GM-CSF elements (Cockerill et al., 1993, 1995b).
linked to an AP-1-like element. In addition, the enhancer These assays indicated that the IL140 and IL190 ele-
ments both had NFATp affinities even higher than thecore also encompassed a consensus AP-2 motif, and a
NF-mE1 motif (Staudt and Lenardo, 1991) lies just down- GM430 probe, while the IL70 and IL280 elements had
affinities intermediate between those of the IL-2 andstream of the XbaI site.
The inducible NFATp/c binding potential of each of the GM430 NFATp elements.
Additional gel shift assays of substituted IL190 probesfour IL-3 enhancer NFATp/c-like motifs was examined
in gel electrophoretic mobility shift assays using either (IL190M1 and IL190M3 in Figure 3B) with purified NFATp
confirmed the existence of two independent NFATpnuclear extracts prepared from Jurkat cells stimulated
with PMA/I (Figure 4) or purified recombinant NFATp sites within the IL190 probe (data not shown). Assays
employing these elements as competitors indicated that(Figure 5A). As controls we included the distal NFAT site
from the human IL-2 promoter and the GM430 NFATp/c the sequence TGGAAAAT functioned as a high affinity
NFATp site and the sequence TGGAGCAC functionedsite from the human GM-CSF enhancer (Cockerill et al.,
1995b). The GM430 probe encompasses the sequence as a low affinity NFATp site (IL190M1 and IL190M3 in
Figure 5D). In assays using nuclear extracts, only theTGGAAAGA, representing just the NFATp/c segment of
the GM420 NFAT site, and is sufficient to support high high affinity NFATp site made a significant contribution
to the formation of NFATp-containing complexes (Fig-affinity NFATp/c binding even in the absence of AP-1
(Cockerill et al., 1995b). The IL-2 probe is a moderate ure 5B).
affinity NFATp site, which binds NFATp and AP-1 in a
highly cooperative fashion. The IL280 Probe Supports Cooperative
Binding of AP-1 and NFATpEach of the four IL-3 enhancer NFATp/c-like elements
formed inducible CsA-sensitive NFATp/c-like com- The IL280 element resembled other composite NFAT
sites that bind NFATp/c and AP-1 cooperatively (Figureplexes with nuclear extracts (Figure 4A), and NFATp/c
complex formation was specifically inhibited in the pres- 3B). Like the IL-2 NFAT probe, the IL280 probe formed
inducible higher order complexes that included bothence of the GM430 oligonucleotide competitor (Figure
4B). The IL190 and IL280 probes also formed additional NFATp/c- and AP-1-like factors and appeared unable
to bind AP-1 independently (Figures 4A, 4B, and 5A).higher order complexes that appeared to contain
NFATp/c and either Oct- or AP-1-like factors. The The IL280 probe was, however, considerably less effi-
cient than the IL-2 NFAT probe at forming these higherNFATp/c-like complexes appeared to contain primarily
NFATp, as all of the NFATp/c-like complexes were order NFAT complexes with nuclear extracts (Fig-
ure 4A).shifted by specific NFATp antisera (Figure 5C; data not
shown). The IL140 motif functioned as a very high affinity Since the IL-2 and IL280 NFAT sites can recruit AP-1
even in the absence of intact AP-1 sites, the IL70, IL140,site, binding NFATp/c-like complexes at least as effi-
ciently as the GM430 element. and IL190 probes were also examined for their ability
to bind AP-1 as part of an NFAT complex. In contrastAssays using purified recombinant NFATp confirmed
that each NFAT-like element associated with NFATp at with the IL280 element, the IL70, IL140, and IL190 ele-
ments did not appear to form any AP-1-containing com-least as efficiently as the IL-2 NFAT probe (Figure 5A).
Unexpectedly, the IL190 probe also formedan additional plexes, as an AP-1 oligonucleotide competitor had no
significant effect on nuclear protein binding (Figure 4B).higher order NFATp complex, suggesting that two
NFATp-binding sites exist within the IL190 element (Fig- Assays with purified recombinant proteins further sug-
gested that there was no significant degree of coopera-ure 5A). Each element was also tested as a competitor
of purified NFATp binding to the GM430 probe so as to tive binding of AP-1 with NFATp to the IL70, IL140, or
IL190 probes (Figure 5A). We did, however, detect someestimate their relative affinities for NFATp (Figure 5D).
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order complexes containing both NFATp/c and Oct fam-
ily proteins binding to overlapping sites. A total of at
least five specific complexes were detected with the
IL190 probe. Two constitutive Oct-like complexes were
detected (Figure 4A) that were specifically inhibited by
Oct DNA competitor (Figure 4B). Above the Oct-1-like
complex, we detected two inducible, CsA-sensitive
NFATp/Oct-like complexes (Figure 4A) that were elimi-
nated in the presence of either NFATp/c or Oct DNA
competitors (Figure 4B). The lower of these two NFATp/
Oct-like complexes appeared to migrate just above an-
other NFATp/c-like band that became visible in the pres-
ence of Oct competitor DNA (Figure 4B), which we be-
lieve represents NFATx (Masuda et al., 1995) (this
NFATx-like band was also visible with the IL140 and
GM430 probes [Figure 4A] and the IL190M2 probe [Fig-
ure 5B]).
The formation of the two NFATp/Oct-like higher order
complexes was absolutely dependent upon the integrity
of the high affinity NFATp/c site and the Oct site, as a
mutation within either site eliminated both of the upper
complexes (IL190M1 and IL190M2 in Figure 5B). The
use of the IL190 probes bearing single site mutations
(IL190M1 and IL190M2 in Figure 5B) also indicated that
the NFATp/c and Oct elements both functioned inde-
pendently as high affinity binding sites. Furthermore,
there was no evidence for cooperativity in the binding
of Oct and NFAT family proteins to the IL190 element.
In the presence of DNA competitors, the individual Oct
and NFATp/c complexes are roughly equal to the sum
of the individual and higher order complexes seen in
the absence of competitor (Figure 4B). The increased
intensity seen with the single complexes may even indi-
cate that there is an element of competition in the bind-
ing of Oct and NFATp/c factors to the IL190 probe.
A mutation within the low affinity IL190 NFATp/c siteFigure 4. The IL-3 Enhancer Contains Four NFATp-Binding Ele-
(IL190M3 in Figure 5B) had no effect on the formation ofments
any of the complexes detected with Jurkat cell extracts.Consensus NFATp/c sequences in the IL-3 enhancer were assayed
These results imply that the higher order complexesfor NFAT-like complex formation with Jurkat cell nuclear extracts
in gel electrophoretic mobility shift assays. involve primarily the high affinity NFATp site that over-
(A) Induction of CsA-sensitive NFATp/c and NFAT-like complexes laps the Oct site and not the more distal low affinity
with Jurkat cell nuclear extracts. Cells were either untreated (nil) or NFATp site.
treated with PMA/I or PMA/I in combination with 0.1 mM CsA. The The identities of the two IL190 NFATp/Oct-like com-
probes employed are indicated above each assay.
plexes were further investigated with the aid of specific(B) Inhibition of specific complex formation in the presence of oligo-
antisera. The addition of NFATp antisera eliminated thenucleotide competitors. Assays include PMA/I-activated Jurkat cell
formation of not only the NFATp-like complex but alsonuclear extract and 25 ng of the indicated AP-1, NFATp/c, or Oct
competitor. Probes used are indicated above each set of assays. both NFATp/Oct-like complexes (Figure 5C). The upper-
Oligonucleotide competitors used were the stromolysin gene AP-1 most band was identified as a NFATp/Oct-1 complex
site, the GM430 NFATp site, and an ideal Oct consensus sequence. on the basis that it was eliminated in the presence of
All probes except the weak octamer probe were labeled to approxi- either Oct-1 or NFATp antisera (Figure 5C) or DNA com-
mately the same specific activity.
petitors (Figure 4B). The identity of the Oct-1 complex
just above the NFATp complex was confirmed as it was
enhancement of NFATp binding to IL70 probe in the eliminated by Oct-1 antisera (Figure 5C). The Oct-like
presence of AP-1 (Figure 5A), and a faint higher order complex below the NFATp band probably represents
NFAT complex became visible in longer exposures of Oct-T3, which is abundant in Jurkat cells (Bhargava et
this assay. We cannot rule out weak AP-1 binding to al., 1993), as it was eliminated by Oct DNA competitor
the IL190 probe, as the higher order IL190 NFATp com- (Figure 4B) but not by Oct-1 or Oct-2 antisera (Figure
plex has the same mobility as the NFAT-like complex 5C; data not shown). In the presence of both NFATp
in Figure 5A. and Oct-1 antisera, the only specific complexes re-
maining were the Oct-T3-like band and a very weak
The IL190 Element Assembles NFATx-like band (Figure 5C). On the basis of the data
Oct-1/NFATp Complexes described above, we suggest that the NFATp/Oct-like
The IL190 binding pattern was especially interesting as complex just above the Oct-1 complex contains pre-
dominantly NFATp and Oct-T3.it provided direct evidence for the existence of higher
Immunity
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Figure 5. Characterization of Transcription Factor Binding to IL-3 Enhancer NFAT-like Elements
(A) Gel electrophoretic mobility shift assays of purified recombinant NFATp and AP-1 binding to NFAT-like elements in the IL-3 enhancer.
Assays include just NFATp, just AP-1, or NFATp plus AP-1. The IL-2 NFAT site is included as a control. The recombinant proteins used here
encompass just the DNA-binding domains and amino acids that support cooperative AP-1/NFATp binding to DNA.
(B) Analysis of NFATp/c and Oct binding to mutated IL190 oligonucleotides in gel electrophoretic mobility shift assays with PMA/I-activated
Jurkat cell nuclear extracts.
(C) Analysis of NFATp/c and Oct binding to the IL190 element using PMA/I-activated Jurkat cell nuclear extracts in the presence and absence
of 1 ml of Oct-1 and 0.2 ml of NFATp antisera.
(D) Relative affinities of NFATp/c motifs for recombinant NFATp. Assays of purified recombinant NFATp binding to the GM430 probe were
performed in the presence or absence of 1, 2, 4, or 8 ng of unlabeled DNA competitors. The relative affinities of the NFATp/c sites were
expressed as their potencies as competitors relative to the GM430 element.
IL-3 Enhancer NFAT-like Elements Synergistic Activation of Oct-1 and NFATp
Motifs in the IL190 ElementActivate Transcription
The four IL-3 enhancer probes that form NFATp com- To determine whether the IL190 NFATp and Oct sites
functioned independently or as a discrete unit, we as-plexes were tested for inducible enhancer function by
placing three head-to-tail copies of each oligonucleo- sayed various mutants of the IL190 motif in Jurkat cell
transfection assays (Figure 6). The IL190, IL190M1, andtide upstream of a truncated GM-CSF promoter frag-
ment (pCLE). This minimal promoter segment (nu- IL190M2 elements were each assayed for enhancer
cleotides 255 to 128) encompasses a conserved
lymphokine element (CLE0) that appears in the proximal
promoters of several cytokines expressed in T cells and
supports only modest inducible activity in the absence
of upstream elements (Cockerill et al., 1996; Masuda et
al., 1993). As with the weakly active thymidine kinase
promoter (Figure 2C), the full-length IL-3 enhancer in-
creased the activity of pCLE by 4-fold in Jurkat cells
(Figure 6).
Three of the multimerized NFAT-like elements had
enhancer capabilities equal to or greater than the full-
length IL-3 enhancer when placed directly upstream of
the minimal GM-CSF promoter (Figure 6). The IL280
NFAT trimer increased the activity of the promoter by
4-fold and had an activity similar to the full-length en-
hancer. The trimer of the IL190 NFATp/Oct element was
three times as active as the full-length enhancer, in-
creasing the activity of the promoter by 13-fold. Surpris-
Figure 6. Three NFAT-like Elements in the IL-3 Enhancer Functioningly, the IL140 high affinity NFATp element functioned
as Transcriptional Activatorsas an even more powerful enhancer element than the
Three copies of each NFAT-like element were placed upstream ofIL190 element, even in the absence of additional tran-
the GM-CSF CLE0 element in the luciferase reporter plasmid pCLE.scription factor sites. Not all NFATp motifs can function
Plasmids were transfected into Jurkat cells and assayed for PMA/
in isolation, however, as the moderate affinity IL70 I-inducible enhancer activity, using the full-length IL-3 enhancer
NFATp motif had no enhancer activity under these con- (B1.2) as a control. Error bars represent the standard error of the
mean of at least four transfections.ditions.
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function as trimers in front of the pCLE promoter (Figure IL-3 enhancer resembled the GM-CSF enhancer and the
IL-2 and IL-4 promoters. The GM-CSF enhancer has6). A mutation in the Oct element (IL190M2) abolished
enhancer activity, indicating that the NFATp site could three functional NFATp/c sites linked to AP-1 sites
(Cockerill et al., 1995b), and the IL-2 and IL-4 promotersnot function on its own as a transcriptional activator. A
mutation within the high affinity NFATp motif (IL190M1) each have up to four NFATp/c sites that are linked to
AP-1 or Oct sites (or both) (Chuvpilo et al., 1993; Masudaled toa 6-folddecrease in activity, indicating that the Oct
site is also inefficient as an isolated enhancer element. et al., 1993; Pfeuffer et al., 1994; Rao, 1994; Rooney et
al., 1995a, 1995b; Schreiber and Crabtree, 1992; SzaboThese assays suggested that despite an absence of
cooperative binding, there is a high degree of synergy et al., 1993; Todd et al., 1993). The IL-3 enhancer encom-
passed three functional NFATp/c elements that poten-in the functions of Oct and NFAT family proteins in the
activation of the IL190 element. tially account for most of the activity of the enhancer.
These three elements were all located within the 220 bp
HinfI–XbaI core region, which was almost as active asDiscussion
1.2 kb BglII enhancer fragment. The two most active
IL-3 enhancer elements (IL140 and IL190) were also theThe IL-3 Promoter Is Activated by a T
highest affinity NFATp sites and appeared to be locatedCell–Specific Enhancer
at the center of the DH site. The IL70 moderate affinityThe human IL-3 gene is expressed almost exclusively
NFATp site and the NFm-E1 motif did not appear to bein T cells, in contrast with the closely linked GM-CSF
essential since they could be deleted without significantgene, which is expressed by a number of cell types at
loss of enhancer activity.sites of inflammation. In this study, we identified a T
cell–specific enhancer 14 kb upstream of the human
The Role of NFATp/c MotifsIL-3 gene that is likely to play a role in the T cell–specific
in the IL-3 Enhanceractivation of the IL-3 gene. The IL-3 enhancer responded
The mechanisms by which NFATp/c family proteinsto activation by a combination of inducing agents
function as transcriptional activators remain poorly(PMA/I) that activate the Ca21 and protein kinase C sig-
defined. NFATp/c sites do, however, usually functionnaling pathways that normally originate from the TCR.
in cooperation with other transcription factor–bindingThe IL-3 promoter and enhancer both appeared to be
sites. NFATp/c may play a role in the modification ofrepressed in the presence of CsA, which blocks the Ca21
chromatin structure, as NFATp/c sites are closely asso-signaling pathways by targeting the Ca21-dependent
ciated with inducible CsA-sensitive DH sites in the GM-phosphatase calcineurin. In many ways the pattern of
CSF enhancer and IL-2 promoter (Cockerill et al., 1995b;induction of the IL-3 enhancer mirrored that of the IL-3
Durand et al., 1987). As the closely linked IL140 andgene as well as several other cytokine genes such as
IL190 elements also existed at the center of an inducibleIL-2 and GM-CSF.
DH site, they may function partly by disrupting the inter-IL-3 enhancer activation was T cell specific at the
actions between histone proteins and the enhancer tolevels of both chromatin structure and transcriptional
form the DH site. The IL140 element had nuclear proteinactivation. The DH site within the IL-3 enhancer most
binding properties resembling those of theGM430 probelikely represents a nucleosome-free region, and this al-
(Figure 4A), which represents just the high affinitytered chromatin structure appeared in activated Jurkat
NFATp/c-binding region of the GM420 element (Cock-T cells, but not in fibroblasts, HeLa cells, or a B cell line
erill et al., 1995b). We have preliminary evidence that(Figure 1). We have also recently detected the DH site
the GM430 element is sufficient to support the inductionin activated CEM T cells, but not in endothelial cells
of a DH site even in the absence of the closely linked(P. N. C., unpublished data). In contrast, the DH site
AP-1-binding site (P. N. C., unpublished data). Thesewithin the GM-CSF enhancer is inducible in every cell
findings may, therefore, implicate the IL140 and IL190type examined that has the capacity to express GM-
NFATp/c sites as the DNA elements that mediate theCSF (Figure 1; Cockerill et al., 1995a; P. N. C., unpub-
induction of the DH site within the IL-3 enhancer.lished data).
From the evidence obtained with the IL70 andIn transfection assays, the IL-3 enhancer increased
IL190M2 constructs (Figure 6), itwas apparent that somethe inducible levels of reporter gene activity by 2- to 10-
NFATp/c sites are poor transcriptional activators in thefold in Jurkat and CEM T cells, but was entirely inactive
absence of other closely linked transcription factor–in other cell types that normally express GM-CSF but
binding sites. In contrast, the IL140 high affinity NFATp/c
not IL-3. In the context of the IL-3, GM-CSF, or thymidine
site did function as a powerful enhancer element even
kinase promoters, the IL-3 enhancer had a level of activ-
in the absence of any obvious adjacent transcription
ity in T cell lines that was indistinguishable from that of
factor–binding sites. The IL140 NFATp complex was
the human GM-CSF enhancer (Osborne et al., 1995;
clearly unable to recruit AP-1, even when purified recom-
K. N. D., A. G. B., J. R. Burrows, and P. N. C., unpublished
binant proteins were employed. However, if the IL140
data).
element has the ability to create a DH site that encom-
passes nearby elements, it may still function in part
The IL-3 Enhancer Resembles IL-2, IL-4, by cooperating with other transcription factor–binding
and GM-CSF Gene Regulatory Elements sites. In the native enhancer, it may cooperate with the
The IL-3 enhancer appeared to be activated principally IL190 element. In the pCLE-IL140 transfection experi-
by an array of NFATp/c elements operating in coopera- ments, where it functioned as a powerful enhancer (Fig-
ure 6), it may be acting to maintain the nearby the CLE0tion with either Oct or AP-1 elements. In this regard the
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promoter element in a nucleosome-free state. An alter- NFATp-deficient mice express reduced levels of all three
cytokines (Hodge et al., 1996). The role of Oct-T3 innative explanation for the high activity of the IL140
NFATp/c site could be the existence of another, as yet cytokine gene regulation is unclear as this remains an
ill-defined Oct-like factor. The IL190 Oct element mayunidentified factor-binding site within the IL140 el-
ement. also require a lymphoid-specific coactivator. In B cells,
for example, Oct sites play an important role in regulat-
ing immunoglobulin gene expression (Staudt and Len-
Cooperation between NFATp/c and Oct ardo, 1991), and the B cell–specific coactivator Bob1
Elements in T Cell–Specific Genes contributes to the B cell–specific and promoter-specific
Although we have yet to define the basis for the T cell utilization of Oct elements (Gstaiger et al., 1996). Hence,
specificity of the IL-3 enhancer, we have narrowed our the IL-3 enhancer may only function in a highly restricted
focus to the IL190 composite NFATp/Oct element. This population of cells that express specific combinations
study provides evidence that Oct and NFATp/c factors of Oct and NFATp/c factors and other coactivators.
can bind simultaneously to overlapping sites and that If, as suggested above, NFATp/c functions ineffi-
closely linked Oct and NFATp/c sites can function in a ciently on its own, then the specific pairing of NFATp/c
highly synergistic fashion. Preliminary studies suggest with other factors is a powerful means of directing tightly
that the IL190 element can function as an enhancer controlled cell-specific gene activation. As the IL-3 pro-
element in T cells but not in endothelial cells, while the moter also requires AP-1, the combination of at least
GM-CSF enhancer GM420 element can function as an AP-1, NFATp/c, and Oct factors may be required for
enhancer in both cell types (J. R. Burrows and P. N. C., IL-3 gene activation. The GM-CSF enhancer, on the
unpublished data). other hand, is not reliant on Oct factors and is known
NFATp/c and Oct elements are known to play central to function in endothelial cells which express NFATp
roles in directing the lymphoid cell–specific activation and AP-1. The dual requirement for AP-1 and NFATp/c
of other cytokine genes, such as IL-2 and IL-4 (Chuvpilo in IL-2, IL-3, and GM-CSF gene expression ensures that
et al., 1993; Masuda et al., 1993; Pfeuffer et al., 1994; at least two distinct signaling pathways must be acti-
Rao, 1994; Rooney et al., 1995a, 1995b; Schreiber and vated before gene activation can occur.
Crabtree, 1992; Szabo et al., 1993; Todd et al., 1993). It is likely that more detailed future studies will dis-
Furthermore, the pairing of an NFATp/c site with an Oct cover roles for additional transcription factors in the
site is the most striking difference between the IL-3 regulation of the IL-3 enhancer. This initial study is not
and GM-CSF enhancers, which clearly have different a comprehensive survey and has focused on elements
functions despite their overall similarities. In the IL-2 that are conserved among several cytokine genes. The
promoter, there are five NFATp/c sites and two Oct sites NFATp sites in the IL-3 enhancer may, for example,
(Rooney et al., 1995b; Schreiber and Crabtree, 1992). cooperate with architectural proteins such as the HMG
One of the IL-2 promoter NFATp/c sites is immediately I/Y proteins (Chuvpilo et al., 1993). The T cell–specific
upstream from closely linked AP-1 and Oct sites, and regulation of the IL-3 gene could involve additional tis-
there is evidence for the formation of DNA complexes sue-specific factors analogous to c-maf, which plays a
containing all three of these factors (Rooney et al., central role in directing the T helper type 2 T cell–specific
1995b). In the IL-4 promoter, there exist at least four expression of the IL-4 gene (Ho et al., 1996).
NFATp/c sites, three of which are linked to weak Oct-
binding sites. However, unlike the IL190 element, the
IL-4 promoter elements appear to be unable to bind Regulation of the IL-3/GM-CSF Locus
On the basis of the above findings, we suggest that theNFATp/c and Oct factors simultaneously (Pfeuffer et al.,
1994). The IL-3 promoter also encompasses an Oct site IL-3 and GM-CSF genes are independently regulated
rather than coactivated by the intergenic GM-CSF en-(Davies et al., 1993), and we have found that the nearby
CK1 element also has the capacity to bind NFATp hancer. Fitzpatrick and Kelso (1995) have demonstrated
that, even among T cell clones, the IL-3 and GM-CSF(K. N. D. and P. N. C., unpublished data).
We are currently exploring mechanisms by which genes can be differentially expressed. Paradoxically,
however, the IL-3 and GM-CSF promoters can be acti-composite NFATp/Oct elements such as the IL190 ele-
ment might function as T cell–specific enhancer or pro- vated equally well by an upstream IL-3 or GM-CSF en-
hancer. The IL-3 gene may, therefore, also rely on addi-moter elements. Significantly, it is known that cell-spe-
cific transcription factors exist within both the Oct and tional flanking DH sites for its correct regulation in vivo
(Figure 7). These DNA elements might help to partitionNFATp/c families of proteins. The activation of the IL190
element might, therefore, be dependent on the coex- the GM-CSF/IL-3 locus into distinct chromatin domains
that could then be activated independently in a tissue-pression of specific NFATp/c and Oct family proteins.
We have detected Oct-1 and an Oct-T3-like factor as specific manner. The cluster of ubiquitous DH sites
downstream of the IL-3 gene may represent a boundarythe predominant Oct family proteins in Jurkat, CEM, and
Molt4 T cells, and Oct-1 and Oct-2 as the predominant element that segregates the IL-3 gene from the effects
of GM-CSF enhancer activation in cell types that ex-Oct proteins in peripheral blood T cells (Figure5; A.G. B.,
J. B. Burrows, and P. N. C., unpublished data). The press GM-CSF and NFAT but not IL-3. Boundary ele-
ments were first identified in Drosophila and have thespecific combination of Oct-2 and NFATc or NFATp oc-
curs in lymphoid cells, and this could relate to the ability capacity to shield genes from adjacent regulatory ele-
ments (Kellum and Schedl, 1991). In addition, the IL-3of T cells to express IL-2, IL-3, and IL-4. NFATp is impli-
cated in IL-3, IL-4, and GM-CSF gene expression since enhancer might cooperate in vivo with the cluster of DH
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Figure 7. Regulatory Elements within the IL-
3/GM-CSF Locus
Summary of the properties of DH sites identi-
fied in this and previous studies (Cockerill et
al., 1993, 1995a).
by cloning the 1.2 kb BglII fragment encompassing the human IL-3sites located just upstream of the IL-3 gene. These DH
enhancer upstream of the TK promoter in the BamHI site of pTK81.sites, extending up to 4 kb upstream of the gene, are
The plasmid pGM contains the human GM-CSF promoter upstreamboth constitutive and T cell specific. One of these sites
of the luciferase gene (Osborne et al., 1995). pGMB1.2 and pGMSV40
corresponds to the promoter that associates with at were made by cloning either a 1.2 kb BglII fragment encompassing
least one T cell–specific factor (Davies et al., 1993). the IL-3 enhancer or a 158 bp fragment of the SV40 enhancer (113
to 270), respectively, into a BglII site upstream of the GM-CSF pro-Some cell-specific genes, such as the globin genes
moter in pGM. The plasmid pCLE contains nucleotides 255 to 128(Dillon and Grosveld, 1993) and the TCR genes (Diaz et
of the human GM-CSF promoter and is the same as pGM55 (Cock-al., 1994), are regulated by locus control regions (LCRs),
erill et al., 1996). pCLEB1.2 had a 1.2 kb BglII fragment of the humanwhich can usually bedetected as clusters of constitutive
IL-3 enhancer placed upstream of the 255 GM-CSF promoter in the
cell-specific DH sites. LCRs typically cooperate with BglII site of pCLE. All other pCLE constructs were made by inserting
enhancers and promoters to maintain chromatin do- three head-to-tail copies of the appropriate oligonucleotides in the
BglII site of pCLE. All DNA fragments (unless otherwise indicated)mains in an active conformation. The DH sites just up-
were inserted in the same orientation relative to the promoters asstream of the IL-3 gene have some of the properties
they exist in the GM-CSF/IL-3 locus.expected of LCRs. Hence, we suggest that the IL-3 en-
hancer cooperates with other upstream and down-
stream elements to activate the IL-3 gene in a T cell– Oligonucleotides
specific manner. Oligonucleotide duplexes used as probes and competitors and in
the construction of reporter plasmids had the sequences listed be-
low. Each strand of these duplexes was synthesized with a 59 GATCExperimental Procedures
extension for cloning purposes. The sequence is depicted for one
strand only.DH Site Analyses
DH sites in Jurkat cells, CEM cells, human umbilical vein endothelial IL70, gatccAAATACTGGAAAACCAAAGAGAATCTGAAA; IL140,
gatctGCCCAGTGGAAAAAGCAAGGGTTCTTGCCG; IL190, gatccGGcells (HUVECs), Ball-1 cells, and human embryonic lung fibroblasts
(HEL cells) were assayed as described previously (Cockerill et al., GTGCTCCATGGAAAATGCAAATCTACTa; IL190 M1, gatccGGGTGC
TCCATGGccAATGCAAATCTACTa; IL190 M2, gatccGGGTGCTCCA1993). In brief, nuclei were isolated from cells by lysis in 0.1% Noni-
det P-40 and resuspended to z0.4 mg/ml nucleic acid (optical den- TGGAAAATGCccATCTACTa; IL190 M3, gatccGGGTGggCCATGGA
AAATGCAAATCTACTa; IL280, gaTCTAGAGGCTGGAAAACTGTAGsity at 260 nm of an aliquot in 1 M NaOH 5 10 absorbance units/
milliliter). Aliquots of nuclei were digested for 3 min at 228C with CTCACAGCAGG; IL-3 CK-1, agcTTTTCTATGGAGGTTCCATGTCAG
ATA; IL-2 NFAT, gatcCGAAAGGAGGAAAAACTGTTTCATACAGAAG;DNase I (Worthington) at 2–20 U/ml in nuclei isolation buffer con-
taining 1 mM CaCl2. DNA was purified, digested with restriction octamer, gatcCCTAATTTGCATG; AP-1, gatcTGGATCACCCGCAGC
TTGACTCATCCTTGCA; GM430, gatcTCACACATCTTTCTCATGGAenzymes, electrophoresed on a 0.8% agarose gel, blotted onto a
Hybond N membrane (Amersham), and hybridized to 32P-labeled AAGATGA.
All nucleotides that differ from the natural sequence are depictedprobes. The IL-3 DH site was mapped using BamHI-digested DNA
and a 0.7 kb EcoRI–BamHI fragment of l-66 DNA (Cockerill et al., in lowercase. The AP-1-binding sequence is derived from the stro-
melysin gene, and the GM430 NFATp/c site is derived from the GM-1993; a gift of S. Clark and Y.-C. Yang, Genetics Institute, Boston,
MA) that extends upstream from the BamHI site located 10 kb up- CSF enhancer (Cockerill et al., 1995b). The octamer is derived from
an immunoglobulin gene enhancer (Staudt and Lenardo, 1991) andstream of the human IL-3 gene. The GM-CSF enhancer DH site was
mapped as described previously (Cockerill et al., 1993). is used as a competitor of Oct family proteins.
Plasmid Construction
pIL3 was made by cloning a 613 bp fragment of the human IL-3 Cell Culture
The Jurkat T leukemic cell line, Ball-1 B leukemic cell line, KG1apromoter (2559 to 150) into a HindIII site of the pXP1 (Nordeen,
1988) luciferase reporter plasmid. The IL-3 promoter fragment was myeloid leukemic cell line, HeLa cervical carcinoma cell line, 5637
bladder carcinoma epithelial cell line, and HEL cells were culturedobtained as a HindIII fragment of a PCR product generated using
the oligonucleotide primers GTGTCAAGGAGAAGCTTCCCGAAG in RPMI containing 10% FCS. The CEM leukemic T cell line was
cultured in RPMI containing 15% FCS. HUVECs were cultured asCCC (2559) and CGGGCAGGCGGCTCAAGCTTGGATCGGCAGG
(150) and the DNA clone l-66 (Cockerill et al., 1993). pIL3B1.2 and previously described (Cockerill et al., 1995a).
pIL3B1.2R were made by cloning the 1.2 BglII fragment encom-
passing the IL-3 enhancer into a BglII site upstream of the IL-3
promoter in pIL3 in either the normal or opposite orientation relative Transfections and Luciferase Assays
All cells except HUVECs were transfected with 5 mg of CsCl-purifiedto the promoter, respectively. The 1.2 kb BglII fragment containing
the enhancer was isolated from the plasmid pG2 (a gift of E. Frolova, plasmid DNA by electroporation, cultured for 20–24 hr, stimulated
with 20 ng/ml PMA and 1 mM calcium ionophore A23187 (PMA/I) forShemyakin Institute of Organic Chemistry, Moscow, Russia) and is
normally located approximately 13.5–14.7 kb upstream of the human 9 hr, and assayed for luciferase reporter gene activities as previously
described for Jurkat cells (Osborne et al., 1995). HUVECs wereIL-3 gene (Frolova et al., 1991). pIL3NA330 and pIL3HX220 were
made by cloning either a 330 bp NruI–AccI fragment of the IL-3 transfected with 20 mg of CsCl-purified plasmid DNA by the DEAE–
dextran procedure, cultured for 36 hr, stimulated with 20 ng/ml PMAenhancer or a 220 bp HinfI–XbaI fragment of the IL-3 enhancer
into Ecl136-cut pIL3. pTK81 is the plasmid pT81luc (Nordeen, 1988) and 2 mM calcium ionophore A23187 for 9 hr, and assayed for
luciferase reporter gene activities as previously described (Cockerillconsisting of a herpes simplex thymidine kinase (TK) promoter (281
to 152) in a luciferase reporter gene plasmid. pTK81B1.2 was made et al., 1995a).
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Gel Electrophoretic Mobility Shift Assays M.A. (1993). The granulocyte-macrophage colony-stimulating fac-
tor/interleukin 3 locus is regulated by an inducible cyclosporin AGel shift assays and preparation of nuclear extracts were as pre-
viously described (Cockerill et al., 1995b), except that assays em- sensitive enhancer. Proc. Natl. Acad. Sci. USA 90, 2466–2470.
ployed 5 mg of nuclear extract and 2 mg of poly(dI–dC) in a 15 ml Cockerill, P.N., Bert, A.G., Jenkins, F., Ryan, G.R., Shannon, M.F.,
volume. In some instances, nuclear extracts were enriched by bind- and Vadas, M.A. (1995b). Human granulocyte-macrophage colony-
ing to heparin Sepharose, washing with 0.15 M KCl, and eluting with stimulating factor enhancer function is associated with cooperative
0.45 M KCl before the final dialysis. Assays of nuclear proteins interactions between AP-1 and NFATp/c. Mol. Cell. Biol. 15, 2071–
used nuclear extracts prepared from unstimulated cells and cells 2079.
stimulated for 2–3 hr with 20 ng/ml PMA and 2 mM A23187 in the
Cockerill, P.N., Osborne, C.S., Bert, A.G., and Grotto, R.J.M. (1996).presence and absence of 0.1 mM CsA. Some assays were performed
Regulation of GM-CSF gene transcription by core-binding factor.in the presence of specific antisera. The R59 antiserum raised
Cell Growth Differ. 7, 917–922.against murine NFATp was used as described previously (Cockerill
Curran, T., and Franza, B.R. (1988). Fos and Jun: the AP-1 connec-et al., 1995b). The Oct-1 antiserum was a gift from R. Sturm and
tion. Cell 55, 395–397.was raised against human Oct-1 (Sturm et al., 1988). The Oct-2
antiserum was raised against murine Oct-2 and was a gift from L. Davies, K., TePas, E.C., Nathan, D.G., and Mathey-Prevot, B. (1993).
Corcoran (Walter and Eliza Hall Institute, Melbourne, Australia). To Interleukin-3 expression by activated T cells involves an inducible,
reconstitute NFAT-like complexes from purified recombinant pro- T-cell-specific factor and an octamer binding protein. Blood 81,
teins, we used 4 ng of wbJun and 2.5 ng of wbFos as the source 928–934.
of AP-1 and 0.1 ng of truncated NFATp with 100 ng of poly(dI–dC) Diaz, P., Cado, D., and Winoto, A. (1994). A locus control region in
and 0.2 ng of probe, as previously described (Cockerill et al., 1995b). the T cell receptor a/b locus. Immunity 1, 207–217.
To estimate the relative affinities of NFATp/c elements, we assayed
Dillon, N., and Grosveld, F. (1993). Transcriptional regulation of0.3 ng of purified recombinant NFATp with 0.2 ng of GM430 probe
multigene loci: multilevel control. Trends Genet. 9, 134–137.and included 1, 2, 4, or 8 ng of each element as unlabeled competitor
Durand, D.B., Bush, M.R., Morgan, J.G., Weiss, A., and Crabtree,DNA. For each NFATp/c element, the relative affinity for NFATp,
G.R. (1987). A 275 basepair fragment at the 59 end of the interleukinor potency as a competitor, was expressed as the magnitude of
2 gene enhances expression from a heterologous promoter in re-inhibition of NFATp binding afforded by each element relative to the
sponse to signals from the T cell receptor. J. Exp. Med. 165, 395–407.GM430 element.
Fitzpatrick, D.R., and Kelso, A. (1995). Dissociated expression of
granulocyte-macrophage CSF and IL-3 in short term T cell clonesAcknowledgments
from normal mice. J. Immunol. 155, 5140–5150.
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